The activity of hematopoietic stem cell transplantation in Korea

Bone Marrow Transplantation
J-W Lee, C-C Kim

Abstract

Since the first successful allogeneic hematopoietic SCT (HSCT) was performed in Korea in 1983, there has been a noticeable progress in both the quantity and quality of HSCT over 24 years. There are 38 HSCT centers in Korea and the number of both allogeneic and autologous HSCTs has been increasing every year. As of December 2006, a total of 9561 HSCTs have been carried out in Korea, including 5617 allogeneic (59%) and 3944 autologous HSCTs (41%). The main indications were acute leukemia (3979, 78% allogeneic); lymphoma (1244, 90% autologous); myeloma (939, 92% autologous) and aplastic anemia (938). Characteristically, severe aplastic anemia accounts for a considerable proportion of transplants (10%), compared with western countries. Recently, there has been a marked increase in the number of unrelated transplants and the usage of PBSCs. The pattern of infectious diseases associated with HSCT is quite different. The rapid expansion of unrelated donor pools worldwide has changed the outlook of an unrelated donor search in Korea.

References

Mar 10, 2004·International Journal of Hematology·Jeeyun LeeKeunchil Park
Apr 28, 2006·The New England Journal of Medicine·Edward A Copelan
Jan 11, 2007·Bone Marrow Transplantation·A GratwohlUNKNOWN European Group for Blood and Marrow Transplantation EBMT

❮ Previous
Next ❯

Citations

Mar 2, 2010·Bone Marrow Transplantation·A YoshimiUNKNOWN Asia-Pacific Blood and Marrow Transplantation Group (APBMT)
Jan 1, 2014·Pediatric Transplantation·Meerim ParkUNKNOWN Korean Cord Blood Transplantation Working Party
Jul 10, 2013·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·Mi Suk JeongGeunhye Han
Aug 15, 2009·Current Opinion in Hematology·Alois Gratwohl, Helen Baldomero
May 16, 2019·Bone Marrow Transplantation·Minako IidaUNKNOWN Registry Committee of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT)

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Bone Marrow Transplantation
A YoshimiAsia-Pacific Blood and Marrow Transplantation Group (APBMT)
Bone Marrow Transplantation
L M FoekenDonor Registries Working Group of the World Marrow Donor Association (WMDA)
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Chatchada KaranesDennis L Confer
Bone Marrow Transplantation
Alois GratwohlEuropean Group for Blood and Marrow Transplantation
© 2022 Meta ULC. All rights reserved